AI Verdict
MAXN has stronger fundamentals based on our AI analysis.
MAZE vs MAXN Fundamental Comparison
| Metric | MAZE | MAXN |
|---|---|---|
| Revenue | $0.0 | N/A |
| Net Income | $-131.1M | N/A |
| Net Margin | N/A | N/A |
| ROE | -36.9% | N/A |
| ROA | -33.0% | N/A |
| Current Ratio | 15.50x | N/A |
| Debt/Equity | 0.00x | N/A |
| EPS | $-3.05 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MAZE vs MAXN: Frequently Asked Questions
Is MAZE or MAXN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MAXN has stronger fundamentals. MAZE is rated STRONG SELL (92% confidence) while MAXN is rated HOLD (5% confidence). This is not investment advice.
How does MAZE compare to MAXN fundamentally?
Maze Therapeutics, Inc. has ROE of -36.9% vs Maxeon Solar Technologies, Ltd.'s N/A. Net margins are N/A vs N/A respectively.
Which stock pays higher dividends, MAZE or MAXN?
MAZE has a dividend yield of N/A or no dividend while MAXN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MAZE or MAXN for long term?
For long-term investing, consider that MAZE has STRONG SELL rating with 92% confidence, while MAXN has HOLD rating with 5% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MAZE vs MAXN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MAZE vs MAXN, the AI consensus favors MAXN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.